GLP-1 Telehealth Guide for Connecticut

Yes. Open Water Rx provides fully licensed telehealth GLP-1 weight loss services to eligible patients throughout Connecticut. Complete your health evaluation online, a licensed medical provider reviews it, and your medication ships discreetly if prescribed. No clinic visit required in most cases.

Semaglutide plans are $169/mo and tirzepatide plans are $219/mo. Oral semaglutide is $259/month. Pricing includes provider review, prescription if appropriate, shipping included if prescribed, and ongoing support. Pricing and availability are subject to clinical appropriateness and regulatory change. No insurance required.

In most cases, no. Open Water Rx is a telehealth platform. Your evaluation, provider review, prescription, and ongoing support all happen online. Some states require a synchronous initial visit. Available nationwide in all 50 states.

Provider review timelines vary. Once your provider completes review, your medication ships from a licensed pharmacy. Delivery timelines vary by pharmacy and location. Available nationwide in all 50 states.

Wegovy® and Ozempic® are FDA-approved brand-name medicines containing semaglutide. Zepbound® and Mounjaro® are FDA-approved brand-name medicines containing tirzepatide. Compounded semaglutide and compounded tirzepatide may be prepared by a licensed pharmacy pursuant to an individual prescription; they are not generic versions of those brand medicines and are not represented as bioequivalent, clinically equivalent, or interchangeable. Open Water Rx is a telehealth platform; independent licensed providers make all clinical decisions and will recommend the best option for your health profile.

Compounded semaglutide and tirzepatide are prescribed when an independent, licensed medical provider determines it is clinically appropriate for the individual patient, for example, when a patient requires a specific dosage strength, formulation, or delivery method not available in the commercially manufactured product, or when the patient has a documented clinical need the branded product cannot meet. Compounding is not offered simply as a lower-cost alternative to Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Under FDA regulations, compounding is only legally permissible when there is a valid individual clinical reason. Your prescribing provider makes this determination independently, based solely on your health profile, not on cost or convenience. They are prepared by independent, licensed compounding pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Open Water Rx does not manufacture, compound, or dispense medications.

Open Water Rx serves eligible patients across all of Connecticut, including the Gold Coast communities of Greenwich, Stamford, Darien, New Canaan, Norwalk, Westport, and Fairfield, the Greater Bridgeport cities of Bridgeport, Trumbull, Shelton, and Milford, the Greater New Haven communities of New Haven, Hamden, Branford, Guilford, and Madison, Central Connecticut cities of Middletown, Hartford, West Hartford, Farmington, and Avon, the Farmington Valley towns of Simsbury, Glastonbury, and Manchester, the Naugatuck Valley cities of New Britain, Waterbury, and Danbury, the Northwest Hills communities of Ridgefield and Southbury, and the Southeastern Connecticut village of Mystic. As long as you have a valid Connecticut address and meet clinical eligibility, you can access our telehealth services.

No insurance is required. Open Water Rx offers clear, upfront pricing. Semaglutide $169/mo, tirzepatide $219/mo, and oral GLP-1 options $259/month.

Open Water Rx facilitates access to compounded semaglutide programs for eligible patients in Connecticut. If your independent licensed provider determines semaglutide is clinically appropriate, a prescription may be issued for compounded semaglutide prepared by a licensed compounding pharmacy. Plans are $169/mo and include provider review, prescription if approved, and shipping if prescribed. Open Water Rx does not manufacture, compound, or dispense medications.

Open Water Rx facilitates access to compounded tirzepatide programs for eligible patients in Connecticut. Compounded tirzepatide is a dual GIP/GLP-1 receptor agonist that has demonstrated significant weight loss in clinical trials with FDA-approved formulations. If clinically appropriate, your provider may prescribe compounded tirzepatide from a licensed compounding pharmacy. Plans are $219/mo. Open Water Rx does not manufacture, compound, or dispense medications.

Open Water Rx facilitates access to compounded semaglutide and compounded tirzepatide — not branded Wegovy®, Ozempic®, Mounjaro®, or Zepbound®. Wegovy® (semaglutide) is manufactured by Novo Nordisk. Zepbound® and Mounjaro® (tirzepatide) are manufactured by Eli Lilly. Compounded versions are prepared by independent, licensed compounding pharmacies and are not equivalent to or interchangeable with those branded drugs. All clinical decisions are made by independent licensed providers.

The process is fully online: (1) Complete a secure 5-minute health intake at any time. (2) An independent licensed provider reviews your eligibility — typically within 1–2 business days. (3) If semaglutide or tirzepatide is clinically appropriate, a personalized prescription is issued. (4) Your compounded medication ships discreetly to your Connecticut address from a licensed compounding pharmacy. (5) Ongoing follow-up support is included in your plan. Some states require a synchronous video visit for the initial prescription. Provider review timelines are not guaranteed.

Compounded semaglutide programs are $169/mo. Compounded tirzepatide programs are $219/mo. Oral semaglutide is $259/month. All plans include the independent provider review, your prescription if clinically appropriate, discreet shipping if prescribed, and ongoing support. No hidden fees. No insurance required. Pricing and availability are subject to clinical appropriateness and regulatory change.

Both brands are operated by Open Water Rx LLC. Surfbound Health is our current brand for online enrollment; this site provides program, pricing and support information.

Complete the secure online intake, an independent Connecticut-licensed provider reviews your case and if treatment is clinically appropriate your compounded semaglutide or tirzepatide ships discreetly to your Connecticut address. No clinic visit is required in most cases, and some cases may require a synchronous video visit as determined by your provider. Already on medication? Note your current dose at signup so we can match it when clinically appropriate.

Compounded injectable semaglutide is $169/month and compounded tirzepatide is $219/month. The price is flat month to month wherever you live in Connecticut, with no membership fee and no separate provider fee — provider review, the medication if prescribed, and shipping if prescribed are all included.

No. Open Water Rx is self-pay and does not require or accept insurance, so there is no prior authorization standing between you and a provider review. HSA and FSA funds may apply — check with your plan administrator. Coverage across Hartford, Stamford and New Haven and the rest of Connecticut works the same way: eligible patients are served statewide where permitted by state law.